Fiduciary Wealth Partners LLC Invests $897,000 in Revvity Inc. $RVTY

Fiduciary Wealth Partners LLC acquired a new position in shares of Revvity Inc. (NYSE:RVTY) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,275 shares of the company’s stock, valued at approximately $897,000. Revvity comprises about 0.8% of Fiduciary Wealth Partners LLC’s holdings, making the stock its 17th biggest holding.

Other hedge funds have also recently modified their holdings of the company. MQS Management LLC boosted its stake in Revvity by 23.5% in the second quarter. MQS Management LLC now owns 3,924 shares of the company’s stock valued at $380,000 after acquiring an additional 747 shares in the last quarter. CVA Family Office LLC lifted its holdings in shares of Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after purchasing an additional 181 shares during the last quarter. Sage Mountain Advisors LLC purchased a new stake in shares of Revvity in the 2nd quarter valued at about $246,000. Ethic Inc. boosted its position in shares of Revvity by 7.7% in the 2nd quarter. Ethic Inc. now owns 14,419 shares of the company’s stock valued at $1,410,000 after purchasing an additional 1,028 shares during the period. Finally, Otter Creek Advisors LLC grew its stake in Revvity by 74.2% during the 2nd quarter. Otter Creek Advisors LLC now owns 39,963 shares of the company’s stock worth $3,865,000 after buying an additional 17,023 shares during the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Weiss Ratings reiterated a “sell (d+)” rating on shares of Revvity in a research note on Saturday. Stifel Nicolaus reduced their price target on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a research report on Tuesday, July 29th. Bank of America decreased their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Barclays lowered their price objective on shares of Revvity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Thursday, October 2nd. Finally, Guggenheim started coverage on shares of Revvity in a report on Wednesday, October 15th. They issued a “neutral” rating for the company. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $116.38.

Revvity Price Performance

Shares of NYSE:RVTY opened at $98.91 on Friday. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $129.50. The firm has a market capitalization of $11.48 billion, a price-to-earnings ratio of 41.91, a price-to-earnings-growth ratio of 3.30 and a beta of 0.98. The business’s 50 day simple moving average is $89.38 and its 200-day simple moving average is $92.43. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to analysts’ expectations of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, equities analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, January 16th. Revvity’s dividend payout ratio (DPR) is currently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.